Myopathy associated with atorvastatin-ezetimibe combination therapy

Pharmacotherapy

Volumn 27, Issue 2, 2007, Pages 309-311

  Weffald, Linda A ^a   Flach, Lynn A ^b  

^a KAISER PERMANENTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Atorvastatin; Ezetimibe; Myopathy; Statins

Indexed keywords

ATENOLOL; ATORVASTATIN; CREATINE KINASE; CYANOCOBALAMIN; EZETIMIBE; HYDROCHLOROTHIAZIDE; INSULIN; ISOPHANE INSULIN; LISINOPRIL; POTASSIUM CHLORIDE; POTASSIUM ION; PRIMIDONE; ROSIGLITAZONE;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MYALGIA; MYOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; POTASSIUM BLOOD LEVEL; SIDE EFFECT;

AGED; AZETIDINES; CREATINE KINASE; DRUG COMBINATIONS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MUSCULAR DISEASES; SIMVASTATIN;

EID: 33846817407     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.2.309     Document Type: Article

References (10)

1. McKenney JM, Davidson MH, Jacobson TA, Guyton JR. Final conclusions and recommendations of the national lipid association statin safety assessment task force. Am J Cardiol 2006;97[suppl]:C89-94.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97.
3. Merck/Schering-Plough Pharmaceuticals. Zetia (ezetimibe) product information. Kenilworth, NJ; 2006.
4. Food and Drug Administration. Drugs@FDA. Available from http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm. Accessed May 19, 2006.
5. Fux R, Mörike K, Gundel U, Hartmann R, Gleiter CH. Ezetimibe and statin-associated myopathy [letter]. Ann Intern Med 2004;140:671-2.
6. Phillips PS. Ezetimibe and statin-associated myopathy [comment]. Ann Intern Med 2004;141:649.
7. Simard C, Poitier P. Ezetimibe-associated myopathy in monotherapy and in combination therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Can J Cardiol 2006;22:141-4.
8. Ballantyne CM, Lipka LJ, Sager PT. Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia. Int J Clin Pract 2004;58:653-8.
9. Stein E, Slender S, Mata P, et al. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Am Heart J 2004;148:447-55.
10. Kavi NG, Mengel CE. Hydrochlorothiazide and myalgias [letter]. Ann Intern Med 1988;109:84.